Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified immunoglobulin molecules that specifically bind human VEGF and DLL4

Modified immunoglobulin molecules that specifically bind human VEGF and DLL4

US Patent 9879084 · Granted Jan 30, 2018

Estimated economic value: $1,768,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for alpha-1-antitrypsin disorders2025
Methods and compositions relating to GLP1R variants2025
Antibodies that bind GLP1R2025
Bispecific SARS-CoV-2 antibodies and methods of use2025
Variant nucleic acid libraries for coronavirus2025
Wnt surrogate molecules and uses thereof2025
Antibodies that bind CD3 Epsilon2025
Methods and compositions relating to covid antibody epitopes2025
Methods and compositions relating to adenosine receptors2025
Antibodies that bind CD3 epsilon2024
Dickkopf-1 variant antibodies and methods of use2024
Variant nucleic acid libraries for CRTH22024